Recent Advances in Multiple Myeloma: Applying Real-world Evidence to Clinical Practice

被引：0
作者：
Fonseca, Rafael [1 ]
Costa, Luciano [2 ]
Nooka, Ajay K. [3 ]
Pianko, Matthew James [4 ]
机构：
[1] Mayo Clin, Phoenix, AZ 85054 USA
[2] ONeal Comprehens Canc Ctr, Birmingham, AL USA
[3] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[4] Univ Michigan Hlth, Ann Arbor, MI USA
来源：
ONCOLOGY-NEW YORK | 2022年 / 36卷 / 08期
关键词：
DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：506 / 510
页数：5
相关论文
共 50 条
  • [1] Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice
    Hulin, Cyrille
    de la Rubia, Javier
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Katodritou, Eirini
    Hungria, Vania
    De Samblanx, Hadewijch
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Sioni, Anastasia
    Belch, Andrew
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Potamianou, Anna
    van de Velde, Helgi
    Delforge, Michel
    HEALTH SCIENCE REPORTS, 2019, 2 (01)
  • [2] Multiple myeloma: patient outcomes in real-world practice
    Yong, Kwee
    Delforge, Michel
    Driessen, Christoph
    Fink, Leah
    Flinois, Alain
    Gonzalez-McQuire, Sebastian
    Safaei, Reza
    Karlin, Lionel
    Mateos, Maria-Victoria
    Raab, Marc S.
    Schoen, Paul
    Cavo, Michele
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 252 - 264
  • [3] The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
    Turner, Rose
    Kalff, Anna
    Bergin, Krystal
    Gorniak, Malgorzata
    Fleming, Shaun
    Spencer, Andrew
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
    Mohty, Mohamad
    Terpos, Evangelos
    Mateos, Maria-Victoria
    Cavo, Michele
    Lejniece, Sandra
    Beksac, Meral
    Bekadja, Mohamed Amine
    Legiec, Wojciech
    Dimopoulos, Meletios
    Stankovic, Svetlana
    Soledad Duran, Maria
    De Stefano, Valerio
    Corso, Alessandro
    Kochkareva, Yulia
    Laane, Edward
    Berthou, Christian
    Salwender, Hans
    Masliak, Zvenyslava
    Peceliunas, Valdas
    Willenbacher, Wolfgang
    Silva, Joao
    Louw, Vernon
    Nemet, Damir
    Borbenyi, Zita
    Abadi, Uri
    Pedersen, Robert Schou
    Cernelc, Peter
    Potamianou, Anna
    Couturier, Catherine
    Feys, Caroline
    Thoret-Bauchet, Florence
    Boccadoro, Mario
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10) : E401 - E419
  • [5] Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
    Lecat, Catherine S. Y.
    Taube, Jessica B. B.
    Wilson, William
    Carmichael, Jonathan
    Parrish, Christopher
    Wallis, Gabriel
    Kyriakou, Charalampia
    Lee, Lydia
    Mahmood, Shameem
    Papanikolaou, Xenofon
    Rabin, Neil K. K.
    Sive, Jonathan
    Wechalekar, Ashutosh D. D.
    Yong, Kwee
    Cook, Gordon
    Popat, Rakesh
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany
    Steinmetz, Tilman Hans
    Singh, Moushmi
    Lebioda, Andrea
    Fink, Leah
    Schoehl, Martina
    Rieth, Achim
    Gonzalez-McQuire, Sebastian
    Engelhardt, Monika
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 114 - 122
  • [7] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [8] Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study
    Abello, Virginia
    Armando Mantilla, William
    Idrobo, Henry
    Lucia Sossa, Claudia
    Antonio Salazar, Luis
    Pena, Angela
    Manuel Herrera, Juan
    Guerrero, Paola
    Espinosa, Daniel
    Enrique Quintero-Vega, Guillermo
    Munevar, Isabel
    Galvez, Kenny
    Henao, Alicia
    Gomez, Rigoberto
    Domingo Saavedra, Jose
    Maria Gaviria, Lina
    Osuna, Monica
    Victoria Mateos, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (06) : E405 - E413
  • [9] Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice
    Terpos, Evangelos
    Katodritou, Eirini
    de la Rubia, Javier
    Hungria, Vania
    Hulin, Cyrille
    Roussou, Maria
    Delforge, Michel
    Bries, Greet
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Belch, Andrew
    Ahlberg, Lucia
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Spencer, Mike
    Potamianou, Anna
    van de Velde, Helgi
    Dimopoulos, Meletios A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (04) : 556 - 565
  • [10] Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study
    de la Fuente, Felipe de Arriba
    Mesa, Mercedes Gironella
    Garcia, Miguel Teodoro Hernandez
    Campos, Juan Alonso Soler
    Rodriguez, Susana Herraez
    Belmonte, Maria Jose Moreno
    Lopez, Teresa Regueiro
    Gonzalez-Pardo, Miriam
    Espinosa, Maria Casanova
    PHARMACEUTICALS, 2024, 17 (10)
12345